Ebb & Flow

VaxGen and oncology company Raven caved under the weight of shareholder disapproval last week and terminated their merger plans.

The deal had been scheduled for a shareholder vote on Friday, but was pulled due to stronger than anticipated opposition. VaxGen said it believed the merger would have been defeated...